
Mirati Therapeutics Investor Relations Material
Latest events

Q2 2023
Mirati Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Mirati Therapeutics Inc
Access all reports
Mirati Therapeutics Inc. is a clinical-stage biotechnology company focused on developing targeted cancer therapies. The company specializes in the research and development of treatments aimed at addressing genetic and epigenetic drivers of cancer. Mirati’s pipeline includes precision oncology candidates designed to inhibit specific molecular targets associated with tumor growth and progression. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
MRTX
Country
🇺🇸 United States